Veterinary medicines European public assessment report (EPAR): BTVPUR, inactivated vaccine against bluetongue virus serotypes 1 and 8, Status: Authorised

Pharmacovigilance Risk Assessment Committee (PRAC): 23 - 26 November 2026, European Medicines Agency, Amsterdam, the Netherlands, from 23 November 2026 to 26 November 2026

Veterinary medicines European public assessment report (EPAR): Nobilis Influenza H5N2, adjuvanted inactivated vaccine against avian influenza virus type A, subtype H5, Status: Authorised

Pharmacovigilance Risk Assessment Committee (PRAC): 26 - 29 October 2026, European Medicines Agency, Amsterdam, the Netherlands, from 26 October 2026 to 29 October 2026

Pharmacovigilance Risk Assessment Committee (PRAC): 28 September - 1 October 2026, European Medicines Agency, Amsterdam, the Netherlands, from 28 September 2026 to 1 October 2026

Pharmacovigilance Risk Assessment Committee (PRAC): 31 August - 3 September 2026, European Medicines Agency, Amsterdam, the Netherlands, from 31 August 2026 to 3 September 2026

Pharmacovigilance Risk Assessment Committee (PRAC): 3 - 6 August 2026, European Medicines Agency, Amsterdam, the Netherlands, from 3 August 2026 to 6 August 2026

Pharmacovigilance Risk Assessment Committee (PRAC): 6 - 9 July 2026, European Medicines Agency, Amsterdam, the Netherlands, from 6 July 2026 to 9 July 2026

Pharmacovigilance Risk Assessment Committee (PRAC): 8 - 11 June 2026, European Medicines Agency, Amsterdam, the Netherlands, from 8 June 2026 to 11 June 2026

Pharmacovigilance Risk Assessment Committee (PRAC): 4 - 7 May 2026, European Medicines Agency, Amsterdam, the Netherlands, from 4 May 2026 to 7 May 2026